Effect of Lycopene on prostate cancer among native African patients : an open label Randomised clinical trial in KCMC and Ocean road cancer institute ,Tanzania

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202405488763956

Enrollment

400

Registered

2024-05-15

Start date

2023-03-08

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Urological and Genital Diseases

Interventions

lycopene from tomato paste

Standard of care

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Prostate cancer patients. PSA above 4 ng/ml. Histological diagnosis. Above 50 years.

Exclusion criteria

Exclusion criteria: Allergic to tomato product. Gastrointestinal disease that can interfere with absorption of tomato paste.

Design outcomes

Primary

Measure	Time frame
Reduction in PSA	—

Secondary

Measure	Time frame
Apoptosis improvement in Prostate gland	—

Countries

United Republic of Tanzania

Contacts

Public ContactMfinanga Sayoki

National institute for medical researchTanzania

gsmfinanga@yahoo.com+255784755632

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026